Intima Bioscience

Focus: Intima Bioscience is a New York-based biotechnology company focused on checkpoint cell therapy, operating in gene therapy and cell therapy modalities. The company is in early-stage development with a nascent pipeline.

Gene Therapy Cell Therapy

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Intima Bioscience

AI assessmentNot Hiring

No open roles listed right now. Follow Intima Bioscience to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Fludarabine

Carcinoma, Non-Small-Cell Lung

Phase 1/2

Clinical Trials (1)

NCT05566223CISH Inactivated TILs in the Treatment of NSCLC

Phase 1/2

Help build intelligence for Intima Bioscience

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to contribute to emerging checkpoint cell therapy platform with potential to address solid tumors (lung and GI cancers in Phase 1/2 studies)
Early-stage company environment offers visibility into drug development decisions and potential for meaningful scientific impact
Focused therapeutic area reduces organizational complexity and enables deep expertise building in cell and gene therapy

Watch Out For

No currently open positions (0 active job count), making immediate employment unlikely
Pre-revenue biotech with unknown funding status and employee count creates uncertainty about cash runway and job security
Early pipeline stage (only Phase 1/2 programs) means multi-year timeline before potential value inflection or exit liquidity

Generated by Claude from Intima Bioscience's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Cyclophosphamide

Gastrointestinal Epithelial Cancer

Phase 1/2

Clinical Trials (1)

NCT04426669A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering

Phase 1/2

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Portfolio: 2 clinical trials

Top TAs: Oncology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Oncology

2 pipeline

Marketed

Pipeline